Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: South Korea's Celltrion Plans $513 Million Biologics Facility in Wuhan

Week in Review: China's I-Mab Stages $104 Million NASDAQ IPO

Week in Review: Four China Biopharmas Announce $100+ Million Deals in First Week of 2020

Week in Review: Shanghai's I-Mab Plans $100 Million NASDAQ IPO on January 16

Week in Review: Geneseeq and Elpiscience Close $100 Million VC Rounds; Zai Lab's PARP Inhibitor Approved for China Use

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China